pharmaceutical industry

“Since 2020, changes in how the program operates have created significant challenges for providers across Illinois. Federally qualified health centers in Illinois have lost at least $60 million because of restrictions,” Moeller said. #centerssquare #pharma

Expanding a program that allows profits to grow without transparency while  also delivering minimal benefit to patients at the point-of-sale risks worsening those challenges rather than solving them. #drug #oped

We must advocate for common-sense AI regulation that safeguards our citizens without placing undue burdens on pharmaceutical companies and healthcare innovators. #AI #healthcare

Instead, we call for thoughtful, equitable solutions that support—not sacrifice—the pillars of health and economic well-being in underserved communities. #MFN